Tc-99m nanocolloid and Tc-99m MDP three-phase bone imaging in osteomyelitis and septic arthritis. A comparative study

Clin Nucl Med. 1995 Sep;20(9):772-8. doi: 10.1097/00003072-199509000-00004.

Abstract

The aim of this study was to compare Tc-99m nanocolloid scintigraphy with Tc-99m MDP bone imaging in the diagnosis of osteomyelitis and septic arthritis. Overall, 31 Tc-99m MDP bone scans and 39 Tc-99m nanocolloid studies were performed in 34 patients (15 female, 19 male; mean age, 14.88 years +/- 19.00 years) who were suspected of osteomyelitis and/or septic arthritis. The final diagnoses were established by needle aspiration, cultures, radiography, clinical course, and, in some patients, with CT, ultrasonography, and biopsy. The sensitivity, specificity, and accuracy were 100%, 75%, and 92%, respectively for both Tc-99m MDP and Tc-99m nanocolloid scans in detecting osteomyelitis. For septic arthritis, Tc-99m MDP bone imaging showed 100%, 85%, and 94%, and Tc-99m nanocolloid scans showed 90%, 59%, and 76%, sensitivity, specificity, and accuracy, respectively. These results show that, although both scans are in good agreement for osteomyelitis, for septic arthritis nanocolloid is not specific enough to recommend it to be a complementary method to MDP bone scans.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Arthritis, Infectious / diagnostic imaging*
  • Female
  • Humans
  • Male
  • Osteomyelitis / diagnostic imaging*
  • Predictive Value of Tests
  • Radionuclide Imaging
  • Sensitivity and Specificity
  • Technetium Tc 99m Aggregated Albumin*
  • Technetium Tc 99m Medronate*

Substances

  • Technetium Tc 99m Aggregated Albumin
  • technetium Tc 99m nanocolloid
  • Technetium Tc 99m Medronate